±¹³»µµ¼
ÀÚ¿¬°ú °úÇÐ
±â¼ú°øÇÐ
2013³â 9¿ù 9ÀÏ ÀÌÈÄ ´©Àû¼öÄ¡ÀÔ´Ï´Ù.
Á¤°¡ |
120,000¿ø |
---|
120,000¿ø
ÇÒÀÎÇýÅÃ | |
---|---|
Àû¸³ÇýÅà | |
|
|
Ãß°¡ÇýÅÃ |
|
À̺¥Æ®/±âȹÀü
¿¬°üµµ¼
»óÇ°±Ç
ÀÌ»óÇ°ÀÇ ºÐ·ù
Ã¥¼Ò°³
º» °³Á¤ÆÇ¿¡¼´Â À¯¹æº´¸®¿¡ °üÇÑ ÇÙ½ÉÀûÀÌ°í À¯¿ëÇÑ Á¤º¸µéÀ» ¸íÈ®ÇÏ°í °£°áÇÏ°Ô Àü´ÞÇÏ¿© ÀÔ¹®¼·Î¼ÀÇ ¿ªÇÒÀ» ÇÒ ¼ö ÀÖµµ·Ï ±¸¼ºÇÏ¿´½À´Ï´Ù. ¶ÇÇÑ ºü¸£°Ô ¹ßÀüÇÏ´Â ÀÇÇÐ ºÐ¾ß¿¡ º¸Á¶¸¦ ¸ÂÃß¾î, À¯¹æº´¸® ¿µ¿ª¿¡¼ »õ·ÎÀÌ ¹ßÀüµÈ °³³ä°ú Áö½ÄµéÀ» Ãß°¡ÇÏ°í Á¤¸®ÇÏ¿´½À´Ï´Ù. °¨º°Áø´Ü À§ÁÖ·Î ±¸¼ºÇÑ º»¹® ³»¿ë°ú ÇÔ²² ÀÌÇظ¦ µ½±â À§ÇÑ ÀüÇüÀûÀÎ Áõ·ÊµéÀÇ º´¸® »çÁøÀ» ¸¹ÀÌ Æ÷ÇÔÇÏ¿´°í, À̸¦ ÅëÇØ À¯¹æº´¸®¿¡ ´ëÇØ ÀÌÇØÇÏ°íÀÚ ÇÏ´Â ¿©·¯ ºÐ¾ß ¼±»ý´ÔµéÀÇ ÀÌÇظ¦ ³ÐÈú ¼ö Àֱ⸦ Èñ¸ÁÇÕ´Ï´Ù.
¸ñÂ÷
01 Á¤»óÀ¯¹æ ¹× ¹ß´ÞÀå¾Ö
Normal breast and developmental disorder 1
02 ¿°Áõ¼º º´º¯°ú ºñÁõ½Ä¼º º´º¯
Inflammatory and non-proliferative lesions 11
03 ¼±Áõ°ú °æȺ´º¯
Adenosis and sclerosing lesions 21
04 °ü³» Áõ½Ä¼º º´º¯
Intraductal proliferative lesions 29
05 ¿øÁÖ¼¼Æ÷ º´º¯°ú ´Ü¼ø»óÇǼ¼Æ÷ ºñÁ¤Çü
Columnar cell lesion and flat epithelial atypia 61
06 À¯µÎ¸ð¾ç º´º¯
Papillary lesions 71
07 ¼Ò¿±Á¾¾ç: ¼Ò¿±»óÇdz»¾ÏÁ¾°ú ºñÁ¤Çü¼Ò¿±Áõ½Ä
Lobular neoplasia: lobular carcinoma in situ and atypical lobular hyperplasia 95
08 ħÀ±¼º À¯¹æ¾Ï: ÀÏ¹Ý °³¿ä
Invasive breast cancer: general overview 111
09 ħÀ±¼º À¯¹æ¾ÏÀÇ Á¶Á÷ÇÐÀû À¯Çü
Histologic subtype of invasive breast cancer 127
10 À¯¹æ¾ÏÀÇ Áø´Ü ¹× Ä¡·á¿¡ Áß¿äÇÑ Ç¥ÁöÀÚµé
Biomarkers for breast cancer and special studies for differential diagnosis 157
11 À¯¹æ¾Ï ºÐÀÚÁø´Ü¹ý
Molecular testing for breast cancer 175
12 ¼¶À¯»óÇǼº Á¾¾ç°ú °ú¿ÀÁ¾
Fibroepithelial tumors and hamartomas 187
13 »óÇÇ-±Ù»óÇÇ Á¾¾ç
Epithelial-myoepithelial tumors 199
14 °£¿±Á¾¾ç
Mesenchymal tumors 211
15 À¯µÎ Áúȯ
Nipple disorders 227
16 ³²¼ºÀ¯¹æÁúȯ
Male breast disease 237
17 Ä¡·á ¹ÝÀÀ Æò°¡
Evaluation of treatment effects 245
18 À¯¹æ °Ëü ó¸® ¹× º¸°í¼ ÀÛ¼º
Pathology reporting forms 255
ã¾Æº¸±â 269
ÀúÀÚ¼Ò°³
»ý³â¿ùÀÏ | - |
---|
ÇØ´çÀÛ°¡¿¡ ´ëÇÑ ¼Ò°³°¡ ¾ø½À´Ï´Ù.
ÁÖ°£·©Å·
´õº¸±â»óÇ°Á¤º¸Á¦°ø°í½Ã
À̺¥Æ® ±âȹÀü
ÀÚ¿¬°ú °úÇÐ ºÐ¾ß¿¡¼ ¸¹Àº ȸ¿øÀÌ ±¸¸ÅÇÑ Ã¥
ÆǸÅÀÚÁ¤º¸
»óÈ£ |
(ÁÖ)±³º¸¹®°í |
---|---|
´ëÇ¥ÀÚ¸í |
¾Èº´Çö |
»ç¾÷ÀÚµî·Ï¹øÈ£ |
102-81-11670 |
¿¬¶ôó |
1544-1900 |
ÀüÀÚ¿ìÆíÁÖ¼Ò |
callcenter@kyobobook.co.kr |
Åë½ÅÆǸž÷½Å°í¹øÈ£ |
01-0653 |
¿µ¾÷¼ÒÀçÁö |
¼¿ïƯº°½Ã Á¾·Î±¸ Á¾·Î 1(Á¾·Î1°¡,±³º¸ºôµù) |
±³È¯/ȯºÒ
¹ÝÇ°/±³È¯ ¹æ¹ý |
¡®¸¶ÀÌÆäÀÌÁö > Ãë¼Ò/¹ÝÇ°/±³È¯/ȯºÒ¡¯ ¿¡¼ ½Åû ¶Ç´Â 1:1 ¹®ÀÇ °Ô½ÃÆÇ ¹× °í°´¼¾ÅÍ(1577-2555)¿¡¼ ½Åû °¡´É |
---|---|
¹ÝÇ°/±³È¯°¡´É ±â°£ |
º¯½É ¹ÝÇ°ÀÇ °æ¿ì Ãâ°í¿Ï·á ÈÄ 6ÀÏ(¿µ¾÷ÀÏ ±âÁØ) À̳»±îÁö¸¸ °¡´É |
¹ÝÇ°/±³È¯ ºñ¿ë |
º¯½É ȤÀº ±¸¸ÅÂø¿À·Î ÀÎÇÑ ¹ÝÇ°/±³È¯Àº ¹Ý¼Û·á °í°´ ºÎ´ã |
¹ÝÇ°/±³È¯ ºÒ°¡ »çÀ¯ |
·¼ÒºñÀÚÀÇ Ã¥ÀÓ ÀÖ´Â »çÀ¯·Î »óÇ° µîÀÌ ¼Õ½Ç ¶Ç´Â ÈÑ¼ÕµÈ °æ¿ì ·¼ÒºñÀÚÀÇ »ç¿ë, Æ÷Àå °³ºÀ¿¡ ÀÇÇØ »óÇ° µîÀÇ °¡Ä¡°¡ ÇöÀúÈ÷ °¨¼ÒÇÑ °æ¿ì ·º¹Á¦°¡ °¡´ÉÇÑ »óÇ° µîÀÇ Æ÷ÀåÀ» ÈѼÕÇÑ °æ¿ì ·½Ã°£ÀÇ °æ°ú¿¡ ÀÇÇØ ÀçÆǸŰ¡ °ï¶õÇÑ Á¤µµ·Î °¡Ä¡°¡ ÇöÀúÈ÷ °¨¼ÒÇÑ °æ¿ì ·ÀüÀÚ»ó°Å·¡ µî¿¡¼ÀÇ ¼ÒºñÀÚº¸È£¿¡ °üÇÑ ¹ý·üÀÌ Á¤ÇÏ´Â ¼ÒºñÀÚ Ã»¾àöȸ Á¦ÇÑ ³»¿ë¿¡ ÇØ´çµÇ´Â °æ¿ì |
»óÇ° Ç°Àý |
°ø±Þ»ç(ÃâÆÇ»ç) Àç°í »çÁ¤¿¡ ÀÇÇØ Ç°Àý/Áö¿¬µÉ ¼ö ÀÖÀ½ |
¼ÒºñÀÚ ÇÇÇغ¸»ó |
·»óÇ°ÀÇ ºÒ·®¿¡ ÀÇÇÑ ±³È¯, A/S, ȯºÒ, Ç°Áúº¸Áõ ¹× ÇÇÇغ¸»ó µî¿¡ °üÇÑ »çÇ×Àº¼ÒºñÀÚºÐÀïÇØ°á ±âÁØ (°øÁ¤°Å·¡À§¿øȸ °í½Ã)¿¡ ÁØÇÏ¿© ó¸®µÊ ·´ë±Ý ȯºÒ ¹× ȯºÒÁö¿¬¿¡ µû¸¥ ¹è»ó±Ý Áö±Þ Á¶°Ç, ÀýÂ÷ µîÀº ÀüÀÚ»ó°Å·¡ µî¿¡¼ÀǼҺñÀÚ º¸È£¿¡ °üÇÑ ¹ý·ü¿¡ µû¶ó ó¸®ÇÔ |
(ÁÖ)ÀÎÅÍÆÄÅ©Ä¿¸Ó½º´Â ȸ¿ø´ÔµéÀÇ ¾ÈÀü°Å·¡¸¦ À§ÇØ ±¸¸Å±Ý¾×, °áÁ¦¼ö´Ü¿¡ »ó°ü¾øÀÌ (ÁÖ)ÀÎÅÍÆÄÅ©Ä¿¸Ó½º¸¦ ÅëÇÑ ¸ðµç °Å·¡¿¡ ´ëÇÏ¿©
(ÁÖ)KGÀ̴Ͻýº°¡ Á¦°øÇÏ´Â ±¸¸Å¾ÈÀü¼ºñ½º¸¦ Àû¿ëÇÏ°í ÀÖ½À´Ï´Ù.
¹è¼Û¾È³»
±³º¸¹®°í »óÇ°Àº Åùè·Î ¹è¼ÛµÇ¸ç, Ãâ°í¿Ï·á 1~2Àϳ» »óÇ°À» ¹Þ¾Æ º¸½Ç ¼ö ÀÖ½À´Ï´Ù.
Ãâ°í°¡´É ½Ã°£ÀÌ ¼·Î ´Ù¸¥ »óÇ°À» ÇÔ²² ÁÖ¹®ÇÒ °æ¿ì Ãâ°í°¡´É ½Ã°£ÀÌ °¡Àå ±ä »óÇ°À» ±âÁØÀ¸·Î ¹è¼ÛµË´Ï´Ù.
±ººÎ´ë, ±³µµ¼Ò µî ƯÁ¤±â°üÀº ¿ìü±¹ Åù踸 ¹è¼Û°¡´ÉÇÕ´Ï´Ù.
¹è¼Ûºñ´Â ¾÷ü ¹è¼Ûºñ Á¤Ã¥¿¡ µû¸¨´Ï´Ù.